Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Early invasive assessment of the coronary microcirculation predicts subsequent acute rejection after heart transplantation.

Okada K, Honda Y, Luikart H, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Khush KK, Fearon WF.

Int J Cardiol. 2019 Sep 1;290:27-32. doi: 10.1016/j.ijcard.2019.04.018. Epub 2019 Apr 8.

PMID:
30987835
2.

Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation.

Agbor-Enoh S, Wang Y, Tunc I, Jang MK, Davis A, De Vlaminck I, Luikart H, Shah PD, Timofte I, Brown AW, Marishta A, Bhatti K, Gorham S, Fideli U, Wylie J, Grimm D, Goodwin N, Yang Y, Patel K, Zhu J, Iacono A, Orens JB, Nathan SD, Marboe C, Berry GJ, Quake SR, Khush K, Valantine HA.

EBioMedicine. 2019 Feb;40:541-553. doi: 10.1016/j.ebiom.2018.12.029. Epub 2019 Jan 26.

3.

Association of Endothelin-1 With Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart Transplantation.

Parikh RV, Khush K, Pargaonkar VS, Luikart H, Grimm D, Yu M, Okada K, Honda Y, Yeung AC, Valantine H, Fearon WF.

J Card Fail. 2019 Feb;25(2):97-104. doi: 10.1016/j.cardfail.2018.12.001. Epub 2018 Dec 10.

PMID:
30543947
4.

Risk evaluation using gene expression screening to monitor for acute cellular rejection in heart transplant recipients.

Moayedi Y, Foroutan F, Miller RJH, Fan CS, Posada JGD, Alhussein M, Tremblay-Gravel M, Oro G, Luikart HI, Yee J, Shullo MA, Khush KK, Ross HJ, Teuteberg JJ.

J Heart Lung Transplant. 2019 Jan;38(1):51-58. doi: 10.1016/j.healun.2018.09.004. Epub 2018 Sep 12.

PMID:
30352779
5.

Usefulness of Asymmetric Dimethylarginine to Predict Outcomes After Heart Transplantation.

Parikh RV, Khush K, Luikart H, Sakarovitch C, Lee J, Desai M, Valantine H, Yeung AC, Fearon WF.

Am J Cardiol. 2018 Nov 15;122(10):1707-1711. doi: 10.1016/j.amjcard.2018.07.048. Epub 2018 Aug 21.

6.

Long-term prognostic value of invasive and non-invasive measures early after heart transplantation.

Kobayashi Y, Kobayashi Y, Yang HM, Bouajila S, Luikart H, Nishi T, Choi DH, Schnittger I, Valantine HA, Khush KK, Yeung ACY, Haddad F, Fearon WF.

Int J Cardiol. 2018 Jun 1;260:31-35. doi: 10.1016/j.ijcard.2018.01.070.

PMID:
29622448
7.

Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis.

Agbor-Enoh S, Jackson AM, Tunc I, Berry GJ, Cochrane A, Grimm D, Davis A, Shah P, Brown AW, Wang Y, Timofte I, Shah P, Gorham S, Wylie J, Goodwin N, Jang MK, Marishta A, Bhatti K, Fideli U, Yang Y, Luikart H, Cao Z, Pirooznia M, Zhu J, Marboe C, Iacono A, Nathan SD, Orens J, Valantine HA, Khush K.

J Heart Lung Transplant. 2018 Jul;37(7):925-932. doi: 10.1016/j.healun.2018.01.1305. Epub 2018 Jan 31.

PMID:
29500138
8.

The ratio of circulating regulatory cluster of differentiation 4 T cells to endothelial progenitor cells predicts clinically significant acute rejection after heart transplantation.

Choi DH, Chmura SA, Ramachandran V, Dionis-Petersen KY, Kobayashi Y, Nishi T, Luikart H, Dimbil S, Kobashigawa J, Khush K, Lewis DB, Fearon WF.

J Heart Lung Transplant. 2018 Apr;37(4):496-502. doi: 10.1016/j.healun.2017.10.012. Epub 2017 Oct 22.

PMID:
29198869
9.

Change in lymphocyte to neutrophil ratio predicts acute rejection after heart transplantation.

Choi DH, Kobayashi Y, Nishi T, Luikart H, Dimbil S, Kobashigawa J, Khush K, Fearon WF.

Int J Cardiol. 2018 Jan 15;251:58-64. doi: 10.1016/j.ijcard.2017.10.060. Epub 2017 Oct 22.

10.

The role of complement-fixing donor-specific antibodies identified by a C1q assay after heart transplantation.

Farrero Torres M, Pando MJ, Luo C, Luikart H, Valantine H, Khush K.

Clin Transplant. 2017 Nov;31(11). doi: 10.1111/ctr.13121. Epub 2017 Oct 15.

PMID:
28940521
11.

Impact of Asymmetric Dimethylarginine on Coronary Physiology Early After Heart Transplantation.

Parikh RV, Khush KK, Luikart H, Pargaonkar VS, Kobayashi Y, Lee JH, Sinha S, Cohen G, Valantine HA, Yeung AC, Fearon WF.

Am J Cardiol. 2017 Sep 15;120(6):1020-1025. doi: 10.1016/j.amjcard.2017.06.036. Epub 2017 Jun 29.

PMID:
28754566
12.

Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation.

Agbor-Enoh S, Tunc I, De Vlaminck I, Fideli U, Davis A, Cuttin K, Bhatti K, Marishta A, Solomon MA, Jackson A, Graninger G, Harper B, Luikart H, Wylie J, Wang X, Berry G, Marboe C, Khush K, Zhu J, Valantine H.

J Heart Lung Transplant. 2017 Sep;36(9):1004-1012. doi: 10.1016/j.healun.2017.05.026. Epub 2017 May 20.

PMID:
28624139
13.

Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation.

Fearon WF, Okada K, Kobashigawa JA, Kobayashi Y, Luikart H, Sana S, Daun T, Chmura SA, Sinha S, Cohen G, Honda Y, Pham M, Lewis DB, Bernstein D, Yeung AC, Valantine HA, Khush K.

J Am Coll Cardiol. 2017 Jun 13;69(23):2832-2841. doi: 10.1016/j.jacc.2017.03.598.

14.

Coronary Endothelial Dysfunction and the Index of Microcirculatory Resistance as a Marker of Subsequent Development of Cardiac Allograft Vasculopathy.

Lee JH, Okada K, Khush K, Kobayashi Y, Sinha S, Luikart H, Valantine H, Yeung AC, Honda Y, Fearon WF.

Circulation. 2017 Mar 14;135(11):1093-1095. doi: 10.1161/CIRCULATIONAHA.116.025268. No abstract available.

15.

Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.

Okada K, Fearon WF, Luikart H, Kitahara H, Otagiri K, Tanaka S, Kimura T, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Khush KK, Honda Y.

J Am Coll Cardiol. 2016 Jul 26;68(4):382-92. doi: 10.1016/j.jacc.2016.05.028.

16.

Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma.

Burnham P, Kim MS, Agbor-Enoh S, Luikart H, Valantine HA, Khush KK, De Vlaminck I.

Sci Rep. 2016 Jun 14;6:27859. doi: 10.1038/srep27859.

17.

Invasive Assessment of Coronary Physiology Predicts Late Mortality After Heart Transplantation.

Yang HM, Khush K, Luikart H, Okada K, Lim HS, Kobayashi Y, Honda Y, Yeung AC, Valantine H, Fearon WF.

Circulation. 2016 May 17;133(20):1945-50. doi: 10.1161/CIRCULATIONAHA.115.018741. Epub 2016 Apr 20.

PMID:
27143679
18.

Association of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients.

Kitahara H, Okada K, Tanaka S, Yang HM, Miki K, Kobayashi Y, Kimura T, Luikart H, Yock PG, Yeung AC, Fitzgerald PJ, Khush KK, Fearon WF, Honda Y.

J Heart Lung Transplant. 2016 Jun;35(6):752-9. doi: 10.1016/j.healun.2016.02.002. Epub 2016 Mar 10.

19.

Paradoxical Vessel Remodeling of the Proximal Segment of the Left Anterior Descending Artery Predicts Long-Term Mortality After Heart Transplantation.

Okada K, Kitahara H, Yang HM, Tanaka S, Kobayashi Y, Kimura T, Luikart H, Yock PG, Yeung AC, Valantine HA, Fitzgerald PJ, Khush KK, Honda Y, Fearon WF.

JACC Heart Fail. 2015 Dec;3(12):942-52. doi: 10.1016/j.jchf.2015.07.013. Epub 2015 Nov 11.

20.

Monitoring pharmacologically induced immunosuppression by immune repertoire sequencing to detect acute allograft rejection in heart transplant patients: a proof-of-concept diagnostic accuracy study.

Vollmers C, De Vlaminck I, Valantine HA, Penland L, Luikart H, Strehl C, Cohen G, Khush KK, Quake SR.

PLoS Med. 2015 Oct 14;12(10):e1001890. doi: 10.1371/journal.pmed.1001890. eCollection 2015 Oct.

21.

Noninvasive monitoring of infection and rejection after lung transplantation.

De Vlaminck I, Martin L, Kertesz M, Patel K, Kowarsky M, Strehl C, Cohen G, Luikart H, Neff NF, Okamoto J, Nicolls MR, Cornfield D, Weill D, Valantine H, Khush KK, Quake SR.

Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):13336-41. doi: 10.1073/pnas.1517494112. Epub 2015 Oct 12.

22.

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program.

Reinhartz O, Maeda K, Reitz BA, Bernstein D, Luikart H, Rosenthal DN, Hollander SA.

Ann Thorac Surg. 2015 Sep;100(3):989-94; discussion 995. doi: 10.1016/j.athoracsur.2015.05.111. Epub 2015 Jul 28.

PMID:
26228604
23.

Quality of life and metrics of achievement in long-term adult survivors of pediatric heart transplant.

Hollander SA, Chen S, Luikart H, Burge M, Hollander AM, Rosenthal DN, Maeda K, Hunt SA, Bernstein D.

Pediatr Transplant. 2015 Feb;19(1):76-81. doi: 10.1111/petr.12384. Epub 2014 Nov 12.

PMID:
25388808
24.

Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection.

De Vlaminck I, Valantine HA, Snyder TM, Strehl C, Cohen G, Luikart H, Neff NF, Okamoto J, Bernstein D, Weisshaar D, Quake SR, Khush KK.

Sci Transl Med. 2014 Jun 18;6(241):241ra77. doi: 10.1126/scitranslmed.3007803.

25.

Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection.

Li L, Khush K, Hsieh SC, Ying L, Luikart H, Sigdel T, Roedder S, Yang A, Valantine H, Sarwal MM.

PLoS One. 2013 Dec 16;8(12):e82153. doi: 10.1371/journal.pone.0082153. eCollection 2013.

26.

Temporal response of the human virome to immunosuppression and antiviral therapy.

De Vlaminck I, Khush KK, Strehl C, Kohli B, Luikart H, Neff NF, Okamoto J, Snyder TM, Cornfield DN, Nicolls MR, Weill D, Bernstein D, Valantine HA, Quake SR.

Cell. 2013 Nov 21;155(5):1178-87. doi: 10.1016/j.cell.2013.10.034.

27.

Identification and classification of acute cardiac rejection by intragraft transcriptional profiling.

Holweg CT, Potena L, Luikart H, Yu T, Berry GJ, Cooke JP, Valantine HA, Mocarski ES.

Circulation. 2011 May 24;123(20):2236-43. doi: 10.1161/CIRCULATIONAHA.109.913921. Epub 2011 May 9.

28.

Impact of donor-transmitted atherosclerosis on early cardiac allograft vasculopathy: new findings by three-dimensional intravascular ultrasound analysis.

Yamasaki M, Sakurai R, Hirohata A, Honda Y, Bonneau HN, Luikart H, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Fearon WF.

Transplantation. 2011 Jun 27;91(12):1406-11. doi: 10.1097/TP.0b013e31821ab91b.

PMID:
21512436
29.

Changing trends in infectious disease in heart transplantation.

Haddad F, Deuse T, Pham M, Khazanie P, Rosso F, Luikart H, Valantine H, Leon S, Vu TA, Hunt SA, Oyer P, Montoya JG.

J Heart Lung Transplant. 2010 Mar;29(3):306-15. doi: 10.1016/j.healun.2009.08.018. Epub 2009 Oct 22.

PMID:
19853478
30.

Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus.

Potena L, Fearon WF, Sydow K, Holweg C, Luikart H, Chin C, Weisshaar D, Mocarski ES, Lewis DB, Valantine HA, Cooke JP.

Transplantation. 2008 Mar 27;85(6):827-33. doi: 10.1097/TP.0b013e318166a3a4.

PMID:
18360263
31.

Determinants of lumen loss between years 1 and 2 after cardiac transplantation.

Sakurai R, Yamasaki M, Nakamura M, Hirohata A, Honda Y, Bonneau HN, Luikart H, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Fearon WF.

Transplantation. 2007 Nov 15;84(9):1097-102.

PMID:
17998863
32.

Changes in coronary arterial dimensions early after cardiac transplantation.

Fearon WF, Potena L, Hirohata A, Sakurai R, Yamasaki M, Luikart H, Lee J, Vana ML, Cooke JP, Mocarski ES, Yeung AC, Valantine HA.

Transplantation. 2007 Mar 27;83(6):700-5.

PMID:
17414701
33.

Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation.

Biadi O, Potena L, Fearon WF, Luikart HI, Yeung A, Ferrara R, Hunt SA, Mocarski ES, Valantine HA.

J Heart Lung Transplant. 2007 Apr;26(4):324-30.

PMID:
17403472
34.
35.

T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.

Tu W, Potena L, Stepick-Biek P, Liu L, Dionis KY, Luikart H, Fearon WF, Holmes TH, Chin C, Cooke JP, Valantine HA, Mocarski ES, Lewis DB.

Circulation. 2006 Oct 10;114(15):1608-15. Epub 2006 Oct 2.

PMID:
17015794
36.

Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.

Potena L, Holweg CT, Chin C, Luikart H, Weisshaar D, Narasimhan B, Fearon WF, Lewis DB, Cooke JP, Mocarski ES, Valantine HA.

Transplantation. 2006 Aug 15;82(3):398-405.

PMID:
16906040
37.

Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) study.

Fearon WF, Hirohata A, Nakamura M, Luikart H, Lee DP, Vagelos RH, Hunt SA, Valantine HA, Fitzgerald PJ, Yock PG, Yeung AC.

J Heart Lung Transplant. 2006 Jul;25(7):765-71. Epub 2006 May 24.

PMID:
16818118
38.

Induction therapy for pediatric and adult heart transplantation: comparison between OKT3 and daclizumab.

Chin C, Pittson S, Luikart H, Bernstein D, Robbins R, Reitz B, Oyer P, Valantine H.

Transplantation. 2005 Aug 27;80(4):477-81.

PMID:
16123721
39.

Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience.

Chin C, Naftel DC, Singh TP, Blume ED, Luikart H, Bernstein D, Gamberg P, Kirklin JK, Morrow WR; Pediatric Heart Transplant Study Group.

J Heart Lung Transplant. 2004 Feb;23(2):178-85.

PMID:
14761765
40.

Efficacy and safety of atorvastatin after pediatric heart transplantation.

Chin C, Gamberg P, Miller J, Luikart H, Bernstein D.

J Heart Lung Transplant. 2002 Nov;21(11):1213-7.

PMID:
12431495
41.

Infant heart transplantation at Stanford: growth and neurodevelopmental outcome.

Fleisher BE, Baum D, Brudos G, Burge M, Carson E, Constantinou J, Duckworth J, Gamberg P, Klein P, Luikart H, Miller J, Stach B, Bernstein D.

Pediatrics. 2002 Jan;109(1):1-7.

PMID:
11773534
42.
43.

Pediatric cardiac transplantation: management issues.

Luikart H.

J Pediatr Nurs. 2001 Oct;16(5):320-31. Review.

PMID:
11598864
44.

Efficacy and safety of atorvastatin after pediatric cardiac transplantation.

Chin C, Gamberg P, Miller J, Luikart H, Bernstein D.

J Heart Lung Transplant. 2001 Feb;20(2):230. No abstract available.

PMID:
11250440
45.

Heart transplantation in patients over 54 years of age. Mortality, morbidity and quality of life.

Rickenbacher PR, Lewis NP, Valantine HA, Luikart H, Stinson EB, Hunt SA.

Eur Heart J. 1997 May;18(5):870-8.

PMID:
9152659
46.

Characteristics of patients surviving more than ten years after cardiac transplantation.

DeCampli WM, Luikart H, Hunt S, Stinson EB.

J Thorac Cardiovasc Surg. 1995 Jun;109(6):1103-14; discussion 1114-5.

47.

Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.

Kuo PC, Luikart H, Busse-Henry S, Hunt SA, Valantine HA, Stinson EB, Oyer PE, Scandling JD, Alfrey EJ, Dafoe DC.

Clin Transplant. 1995 Apr;9(2):92-7.

PMID:
7599409
48.

Impact of cyclosporine dose on long-term outcome after heart transplantation.

Valantine H, Hunt S, Gamberg P, Miller J, Luikart H.

Transplant Proc. 1994 Oct;26(5):2710-2. No abstract available.

PMID:
7940848
49.

Current trends in lung transplantation. Lobar transplantation and expanded use of single lungs.

Starnes VA, Lewiston NJ, Luikart H, Theodore J, Stinson EB, Shumway NE.

J Thorac Cardiovasc Surg. 1992 Oct;104(4):1060-5; discussion 1065-6.

PMID:
1405664

Supplemental Content

Loading ...
Support Center